Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III DiseaseMaria Vittoria Dieci, Valentina Guarneri, Vassilena Tsvetkova et al.|Frontiers in Oncology|2019Cited by 71
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive casesElisabetta Di Liso, Valentina Guarneri, Federica Miglietta et al.|ESMO Open|2020Cited by 33
BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysisGrazia Maria Vernaci, Valentina Guarneri, Maria Vittoria Dieci et al.|The Breast|2019Cited by 29
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerFederica Miglietta, Valentina Guarneri, Maria Vittoria Dieci et al.|The Oncologist|2020Cited by 16
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Valentina Guarneri, Luisa Carbognin et al.|British Journal of Cancer|2022Cited by 9